143 related articles for article (PubMed ID: 1769942)
1. Lactate dehydrogenase activity as a cause of metronidazole resistance in Bacteroides fragilis NCTC 11295.
Narikawa S; Suzuki T; Yamamoto M; Nakamura M
J Antimicrob Chemother; 1991 Jul; 28(1):47-53. PubMed ID: 1769942
[TBL] [Abstract][Full Text] [Related]
2. Lactate dehydrogenase activity in Bacteroides fragilis group strains with induced resistance to metronidazole.
Presečki Stanko A; Sóki J; Varda Brkić D; Plečko V
J Glob Antimicrob Resist; 2016 Jun; 5():11-4. PubMed ID: 27436459
[TBL] [Abstract][Full Text] [Related]
3. Pyruvate dehydrogenase activity and metronidazole susceptibility in Bacteroides fragilis.
Tabaqchali S; Pantosti A; Oldfield S
J Antimicrob Chemother; 1983 May; 11(5):393-400. PubMed ID: 6874627
[TBL] [Abstract][Full Text] [Related]
4. Isolation and properties of metronidazole-resistant mutants of Bacteroides fragilis.
Britz ML; Wilkinson RG
Antimicrob Agents Chemother; 1979 Jul; 16(1):19-27. PubMed ID: 475371
[TBL] [Abstract][Full Text] [Related]
5. Differential gene expression in a Bacteroides fragilis metronidazole-resistant mutant.
Diniz CG; Farias LM; Carvalho MA; Rocha ER; Smith CJ
J Antimicrob Chemother; 2004 Jul; 54(1):100-8. PubMed ID: 15150173
[TBL] [Abstract][Full Text] [Related]
6. Metabolic differences between metronidazole resistant and susceptible strains of Tritrichomonas foetus.
Cerkasovová A; Cerkasov J; Kulda J
Mol Biochem Parasitol; 1984 Apr; 11():105-18. PubMed ID: 6379446
[TBL] [Abstract][Full Text] [Related]
7. Metabolic activities of metronidazole-sensitive and -resistant strains of Helicobacter pylori: repression of pyruvate oxidoreductase and expression of isocitrate lyase activity correlate with resistance.
Hoffman PS; Goodwin A; Johnsen J; Magee K; Veldhuyzen van Zanten SJ
J Bacteriol; 1996 Aug; 178(16):4822-9. PubMed ID: 8759844
[TBL] [Abstract][Full Text] [Related]
8. In vitro induced anaerobic resistance to metronidazole in Trichomonas vaginalis.
Kulda J; Tachezy J; Cerkasovová A
J Eukaryot Microbiol; 1993; 40(3):262-9. PubMed ID: 8508165
[TBL] [Abstract][Full Text] [Related]
9. Inducible metronidazole resistance in nim-positive and nim-negative bacteroides fragilis group strains after several passages metronidazole containing columbia agar plates.
Schaumann R; Petzold S; Fille M; Rodloff AC
Infection; 2005 Oct; 33(5-6):368-72. PubMed ID: 16258869
[TBL] [Abstract][Full Text] [Related]
10. Distribution of metronidazole susceptibility factors in obligate anaerobes.
Narikawa S
J Antimicrob Chemother; 1986 Nov; 18(5):565-74. PubMed ID: 3804881
[TBL] [Abstract][Full Text] [Related]
11. Interaction of metronidazole with resistant and susceptible Bacteroides fragilis.
McLafferty MA; Koch RL; Goldman P
Antimicrob Agents Chemother; 1982 Jan; 21(1):131-4. PubMed ID: 7081970
[TBL] [Abstract][Full Text] [Related]
12. Involvement of superoxide dismutase and pyruvate:ferredoxin oxidoreductase in mechanisms of metronidazole resistance in Entamoeba histolytica.
Samarawickrema NA; Brown DM; Upcroft JA; Thammapalerd N; Upcroft P
J Antimicrob Chemother; 1997 Dec; 40(6):833-40. PubMed ID: 9462435
[TBL] [Abstract][Full Text] [Related]
13. [ESBL-positive strains of the Bacteroides fragilis group isolated from patients at the regional hospital center in Płock (Poland)].
Rokosz A; Pawłowska J; Sawicka-Grzelak A; Luczak M
Med Dosw Mikrobiol; 2004; 56(3):245-53. PubMed ID: 15773501
[TBL] [Abstract][Full Text] [Related]
14. The in-vitro activity of metronidazole against Enterobacteriaceae alone and in mixed cultures with Bacteroides fragilis.
Moran FJ; Perez C; Hurtado C; Blanco MT; Prieto J
J Antimicrob Chemother; 1987 Nov; 20(5):657-61. PubMed ID: 3429370
[TBL] [Abstract][Full Text] [Related]
15. [Appearance of metronidazole resistance in Bacteroides fragilis].
Chardon H; Ratignier A; Luneau R; Garrigues B
Nouv Presse Med; 1977 Jun; 6(24):2165. PubMed ID: 905136
[No Abstract] [Full Text] [Related]
16. [Bacteriological and clinical studies on metronidazole in Bacteroides fragilis infections (author's transl)].
Shimada K; Inamatsu T; Sato K
Jpn J Antibiot; 1979 Feb; 32(2):191-4. PubMed ID: 439390
[TBL] [Abstract][Full Text] [Related]
17. Bacteroides fragilis resistant to metronidazole, clindamycin and cefoxitin.
Brogan O; Garnett PA; Brown R
J Antimicrob Chemother; 1989 Apr; 23(4):660-2. PubMed ID: 2745269
[No Abstract] [Full Text] [Related]
18. Resistance to metronidazole among Bacteroides fragilis group strains from humans and marmosets: comparative study.
Pestana AC; Ribeiro RN; Diniz CG; Farias LM; Carvalho MA
Clin Infect Dis; 1997 Sep; 25 Suppl 2():S279-80. PubMed ID: 9310706
[No Abstract] [Full Text] [Related]
19. Inducible metronidazole resistance and nim genes in clinical Bacteroides fragilis group isolates.
Löfmark S; Fang H; Hedberg M; Edlund C
Antimicrob Agents Chemother; 2005 Mar; 49(3):1253-6. PubMed ID: 15728943
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamics of pulse dosing versus standard dosing: in vitro metronidazole activity against Bacteroides fragilis and Bacteroides thetaiotaomicron.
Ibrahim KH; Gunderson BW; Hermsen ED; Hovde LB; Rotschafer JC
Antimicrob Agents Chemother; 2004 Nov; 48(11):4195-9. PubMed ID: 15504841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
